EDP Biotech News
Follow our progress, be the first to know when ColoPlex™ with marker is available.
ColoPlex Biomarker Data Published in Journal of Clinical Oncology
Abstract. Background: Colorectal cancer (CRC) is the third most common cancer worldwide motivating national screening strategies utilizing fecal immunochemical tests (FIT). Blood-based biomarkers could be an alternative method to increase compliance in population-based screening programs for early detection of CRC. We aimed to identify new blood-based biomarkers that could be potential candidates for use in colorectal cancer screening.
AACC 2022
Want to chat with us during AACC? We want to see you in Chicago. Use the link below to schedule time with EDP during the show. We'd love to schedule some time to meet you at AACC next week. In attendance will be Eric Mayer, CEO, Jon Dancy our Business Development...
By Abby Kousouris Published: Aug. 17, 2021 at 7:25 PM EDT KNOXVILLE, Tenn. (WVLT) - A local Knoxville company says they’re seeing more demand for COVID-19 testing. EDP Biotech Corporation has different options available for people who want to find out if they have...
EDP Biotech Finalist in MedCity Pitch Perfect Diagnostic Track
EDP Biotech Finalist in MedCity INVEST Pitch Perfect Diagnostic Track In the age of COVID, diagnostics have become more valuable than ever. EDP Biotech has been fortunate to advance diagnostic programs in colorectal cancer and COVID testing during the last year, and...
EDP Biotech and MDGroup present Decentralized Trials and Clinical Innovation
Best Practices To Stay Beyond COVID: DCTs and Hybrid TRIALS
EDP Biotech to compete in 2021 Tennessee Titans Pitch for Good
EDP Biotech to compete in 2021 Tennessee Titans Pitch for Good! The Tennessee Titans and Nashville Entrepreneur Center (NEC) have launched a collaborative partnership to identify and honor Nashville's top entrepreneur/small business. The Pitch for Good: Tennessee...
EDP Biotech Poster Presentation at AACC 2020 Virtual Expo
EDP Biotech Poster Presentation at AACC This week the newest data results from EDP Biotech's multiplex study involving nearly 2,000 individuals from colorectal cancer organized screening are being presented virtually this week at the 2020 American Association for...
Tulane University’s + UJAMAA Economic Development’s “I Deserve It”! Challenge – EDP Biotech
NOLABA, Partners Name Winners of Health Innovators Challenge Watch the YouTube video above to hear EDP Biotech and other NOLABA Challenge winners discuss their impact in healthcare. Read full Article on BizNewOrleans.com "The third challenge was a unique challenge — I...
EDP Biotech panel discussion at New Orleans Health Innovators
New Orleans Health Innovators Panel Discussion The third annual New Orleans Health Innovators (NOLAHI) Challenge will take place virtually on Thursday, November 19 and Friday, November 20, 2020. NOLAHI creates strategic partnerships between top emerging companies and...
EDP Biotech pitches last week, participating in two upcoming events in November
EDP Biotech pitches last week, participating in two upcoming events in November ON OCTOBER 26 TH, 2020 BY TOM BALLARD Eric Mayer, Chief Executive Officer of EDP Biotech Corporation, alerted us to several important events for the company. One was last week during...
ACS Caner Action Network Tennessee Policy Forum: Precision Medicine and Biomarkers
ACS Cancer Action Network Tennessee Policy Forum: Precision Medicine and Biomarkers EDP Biotech participated in the September 23rd American Cancer Society - Cancer Action Network Tennessee Policy Forum focused on work being done in the field of Precision Medicine and...
Innov865 2020 Impact Awards Teaser
EDP Biotech (who presented our ColoPlex colorectal cancer blood test in 2019) is highlighted this year for our impact in the local community related to our COVID antibody testing response!